Drug Shortage Report for HYDROMORPHONE HYDROCHLORIDE INJECTION, USP
| Report ID | 168499 |
| Drug Identification Number | 02491699 |
| Brand name | HYDROMORPHONE HYDROCHLORIDE INJECTION, USP |
| Common or Proper name | HYDROMORPHONE HYDROCHLORIDE INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROMORPHONE HYDROCHLORIDE |
| Strength(s) | 2MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 1mL |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2022-08-08 |
| Actual start date | 2022-08-08 |
| Estimated end date | Unknown |
| Actual end date | 2022-09-30 |
| Shortage status | Resolved |
| Updated date | 2022-10-02 |
| Company comments | This product will be placed on allocation. Contract customers will be allocated 100% of historical monthly demand. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2022-10-02 | French | Compare |
| v3 | 2022-10-02 | English | Compare |
| v2 | 2022-09-01 | French | Compare |
| v1 | 2022-09-01 | English | Compare |
Showing 1 to 4 of 4